News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
713,241 Results
Type
Article (46057)
Company Profile (301)
Press Release (666883)
Section
Business (208901)
Career Advice (2229)
Deals (36273)
Drug Delivery (106)
Drug Development (82497)
Employer Resources (174)
FDA (16289)
Job Trends (15221)
News (352628)
Policy (33162)
Tag
Academia (2573)
Alliances (50854)
Alzheimer's disease (1335)
Approvals (16263)
Artificial intelligence (212)
Bankruptcy (367)
Best Places to Work (11734)
Biotechnology (221)
Breast cancer (228)
Cancer (1756)
Cardiovascular disease (136)
Career advice (1845)
CAR-T (131)
Cell therapy (378)
Clinical research (66400)
Collaboration (697)
Compensation (370)
COVID-19 (2612)
C-suite (169)
Data (1648)
Diabetes (212)
Diagnostics (6350)
Earnings (86321)
Employer resources (152)
Events (114675)
Executive appointments (579)
FDA (17206)
Funding (625)
Gene therapy (269)
GLP-1 (679)
Government (4407)
Healthcare (18906)
Infectious disease (2727)
Inflammatory bowel disease (128)
Interviews (354)
IPO (16772)
Job creations (3927)
Job search strategy (1588)
Layoffs (456)
Legal (8092)
Lung cancer (256)
Manufacturing (250)
Medical device (13309)
Medtech (13314)
Mergers & acquisitions (19870)
Metabolic disorders (569)
Neuroscience (1764)
NextGen: Class of 2025 (6669)
Non-profit (4522)
Northern California (2120)
Obesity (316)
Opinion (237)
Patents (166)
People (58519)
Phase I (20779)
Phase II (29308)
Phase III (21682)
Pipeline (735)
Postmarket research (2586)
Preclinical (8768)
Radiopharmaceuticals (244)
Rare diseases (343)
Real estate (6253)
Regulatory (22401)
Research institute (2366)
Resumes & cover letters (376)
Southern California (1812)
Startups (3822)
United States (18784)
Vaccines (640)
Weight loss (223)
Date
Today (18)
Last 7 days (611)
Last 30 days (2669)
Last 365 days (35226)
2025 (4559)
2024 (36001)
2023 (40707)
2022 (51899)
2021 (56368)
2020 (54689)
2019 (47153)
2018 (35599)
2017 (33139)
2016 (32595)
2015 (38465)
2014 (33845)
2013 (28963)
2012 (29450)
2011 (30119)
2010 (28199)
Location
Africa (799)
Arizona (214)
Asia (39517)
Australia (6635)
California (4838)
Canada (1725)
China (406)
Colorado (219)
Connecticut (234)
Europe (85972)
Florida (693)
Georgia (165)
Illinois (483)
Indiana (263)
Maryland (755)
Massachusetts (3680)
Michigan (199)
Minnesota (344)
New Jersey (1375)
New York (1372)
North Carolina (868)
Northern California (2120)
Ohio (174)
Pennsylvania (1114)
South America (1187)
Southern California (1812)
Texas (711)
Utah (146)
Washington State (477)
713,241 Results for "edesa biotech inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Edesa Biotech Reports Fiscal 1st Quarter 2025 Results
February 17, 2025
·
9 min read
Press Releases
Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
February 13, 2025
·
6 min read
Press Releases
Edesa Biotech Reports Fiscal Year 2024 Results
December 16, 2024
·
9 min read
Edesa Biotech to Participate in Upcoming Investor Conferences
Edesa Biotech, Inc. announced today that Edesa management plans to participate in the following upcoming investor conferences.
April 2, 2024
·
3 min read
Business
Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results
Edesa Biotech, Inc. reported financial results for the three and six months ended March 31, 2024 and provided an update on its business.
May 10, 2024
·
11 min read
Press Releases
Edesa Biotech’s Founder Makes Strategic Investment in the Company
November 1, 2024
·
5 min read
BARDA Selects Edesa Biotech’s Drug for U.S. Funded Platform Trial in General ARDS
Edesa Biotech, Inc. announced today that its first-in-class drug candidate has been selected by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, for evaluation in a U.S. government-funded clinical study.
June 24, 2024
·
7 min read
Press Releases
Edesa Biotech Announces Upcoming Conference Schedule
October 22, 2024
·
3 min read
Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference
Edesa Biotech, Inc. announced today that the company will participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference scheduled for April 16-17, 2024 in Toronto, Ontario.
April 11, 2024
·
3 min read
Edesa Biotech to Participate in Barclays Global Healthcare Conference
Edesa Biotech, Inc. announced today that company management will participate in the Barclays 26th Annual Global Healthcare Conference, which is being held in Miami, Florida, from March 12-14, 2024.
March 7, 2024
·
3 min read
1 of 71,325
Next
